Specialists weigh indications, outcomes of vitreomacular interface disease treatment

Inroads are being made in the nonsurgical treatment of vitreomacular disease. Ocriplasmin is a game-changer in the treatment of vitreomacular adhesion, vitreomacular traction and associated macular holes, according to some retina specialists.

Full Story →